Veeva Systems is a leading global provider of cloud software solutions for life sciences companies such as drugmakers, biotech companies and medical device makers. The company is steadily growing ...

Veeva Systems (VEEV) is climbing 7% after delivering stronger-than-expected fourth-quarter results and providing full-year earnings per share guidance that came in above analysts' average estimate ...

Subscription services revenue rose to $608.6 million, marking a 16.7% year-over-year growth. Veeva Systems exceeded earnings expectations for Q4 2025, while demonstrating solid revenue growth and ...

Wide-moat Veeva reported solid fourth-quarter results that came in slightly ahead of our forecasts. Total sales of $720 million grew 14% year over year, driven by strong performance in both the ...

My name is Abby and I will be your conference operator, today. At this time, I would like to welcome, everyone, to the Veeva Systems' fiscal 2025 fourth-quarter and full-year results conference call.

Veeva is the leading provider of cloud-based software solutions tailored to the life sciences industry. It provides an ecosystem of products to address the operating challenges and regulatory ...

Subscription services revenue jumped 19% year over year, totaling $561.3 million. Veeva Systems reported strong earnings, surpassing management's expectations across several key metrics.

Veeva Systems (NYSE: VEEV) is a leading global provider of cloud software solutions for life sciences companies – such as drugmakers, biotech companies and medical device makers. The company is ...

In this article, we are going to take a look at where Veeva Systems Inc. (NYSE:VEEV) stands against the other health information services stocks. Health Information Services stocks have become a ...

In the last three months, 9 analysts have published ratings on Veeva Systems VEEV, offering a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings ...

Analysts fell to the sidelines weighing in on Veeva Systems (VEEV – Research Report), Envista Holdings (NVST – Research Report) and Sight Sciences (SGHT – Research Report) with neutral ...